Search Results - "Power, Maryse"

Prognostic Model to Predict Post-Autologous Stem-Cell Transplantation Outcomes in Classical Hodgkin Lymphoma by Chan, Fong Chun, Mottok, Anja, Gerrie, Alina S, Power, Maryse, Nijland, Marcel, Diepstra, Arjan, van den Berg, Anke, Kamper, Peter, d'Amore, Francesco, d'Amore, Alexander Lindholm, Hamilton-Dutoit, Stephen, Savage, Kerry J, Shah, Sohrab P, Connors, Joseph M, Gascoyne, Randy D, Scott, David W, Steidl, Christian

“…Purpose Our aim was to capture the biology of classical Hodgkin lymphoma (cHL) at the time of relapse and discover novel and robust biomarkers that predict…”
Get full text

Gemcitabine, dexamethasone, and cisplatin (GDP) is an effective and well-tolerated salvage therapy for relapsed/refractory diffuse large B-cell lymphoma and Hodgkin lymphoma by Moccia, Alden A., Hitz, Felicitas, Hoskins, Paul, Klasa, Richard, Power, Maryse M., Savage, Kerry J., Shenkier, Tamara, Shepherd, John D., Slack, Graham W., Song, Kevin W., Gascoyne, Randy D., Connors, Joseph M., Sehn, Laurie H.

“…The optimal choice of salvage therapy for patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) or Hodgkin lymphoma (HL) remains unknown…”
Get full text

Incidence and socioeconomic factors in older adults with acute myeloid leukaemia: Real‐world outcomes from a population‐based cohort by Stubbins, Ryan J., Stamenkovic, Maria, Roy, Claudie, Rodrigo, Judith, Chung, Shanee, Kuchenbauer, Florian C., Hay, Kevin A., White, Jennifer, Abou Mourad, Yasser, Power, Maryse M., Narayanan, Sujaatha, Forrest, Donna L., Toze, Cynthia L., Sutherland, Heather J., Nantel, Stephen H., Nevill, Thomas J., Karsan, Aly, Song, Kevin W., Sanford, David S.

“…Objectives Acute myeloid leukaemia (AML) is a disease of older adults, who are vulnerable to socio‐economic factors. We determined AML incidence in older…”
Get full text

Excellent real‐world outcomes of adults with Burkitt lymphoma treated with CODOX‐M/IVAC plus or minus rituximab by Zhu, Katie Y., Song, Kevin W., Connors, Joseph M., Leitch, Heather, Barnett, Michael J., Ramadan, Khaled, Slack, Graham W., Abou Mourad, Yasser, Forrest, Donna L., Hogge, Donna E., Nantel, Stephen H., Narayanan, Sujaatha, Nevill, Thomas J., Power, Maryse M., Sanford, David S., Sutherland, Heather J., Tucker, Tracy, Toze, Cynthia L., Sehn, Laurie H., Broady, Raewyn, Gerrie, Alina S.

“…Summary Treatment of Burkitt lymphoma (BL) with intensive, multi‐agent chemotherapy with aggressive central nervous system (CNS) prophylaxis results in high…”
Get full text

Outcomes of Intermediate Risk Karyotype Acute Myeloid Leukemia in First Remission Undergoing Autologous Stem Cell Transplantation Compared With Allogeneic Stem Cell Transplantation and Chemotherapy Consolidation: A Retrospective, Propensity-score Adjusted Analysis by Limvorapitak, Wasithep, Barnett, Michael J., Hogge, Donna E., Forrest, Donna L., Nevill, Thomas J., Narayanan, Sujaatha, Power, Maryse M., Nantel, Stephen H., Broady, Raewyn, Song, Kevin W., Toze, Cynthia L., Mourad, Yasser Abou, Sutherland, Heather J., Gerrie, Alina S., White, Jennifer, Sanford, David S.

“…We compared outcomes for patients with acute myeloid leukemia with intermediate-risk karyotype receiving consolidation with autologous stem cell…”
Get full text

Outcome of Patients With Non-Hodgkin Lymphomas With Concurrent MYC and BCL2 Rearrangements Treated With CODOX-M/IVAC With Rituximab Followed by Hematopoietic Stem Cell Transplantation by Sun, Haowei, Savage, Kerry J, Karsan, Aly, Slack, Graham W, Gascoyne, Randy D, Toze, Cynthia L, Sehn, Laurie H, Abou Mourad, Yasser, Barnett, Michael J, Broady, Raewyn C, Connors, Joseph M, Forrest, Donna L, Gerrie, Alina S, Hogge, Donna E, Narayanan, Sujaatha, Nevill, Thomas J, Nantel, Stephen H, Power, Maryse M, Sutherland, Heather J, Villa, Diego, Shepherd, John D, Song, Kevin W

“…Micro-Abstract Use of CODOX-M/IVAC+R (cyclophosphamide, vincristine, doxorubicin, methotrexate, cytarabine, ifosfamide, and etoposide, combined with rituximab)…”
Get full text

Allogeneic haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: outcome in a 20-year cohort by Toze, Cynthia L., Dalal, Chinmay B., Nevill, Thomas J., Gillan, Tanya L., Abou Mourad, Yasser R., Barnett, Michael J., Broady, Raewyn C., Forrest, Donna L., Hogge, Donna E., Nantel, Stephen H., Power, Maryse M., Song, Kevin W., Sutherland, Heather J., Smith, Clayton A., Narayanan, Sujaatha, Young, Sean S., Connors, Joseph M., Shepherd, John D.

“…Summary The curative potential of allogeneic haematopoietic stem cell transplant (allo HSCT) in chronic lymphocytic leukaemia CLL is established, with a…”
Get full text

Cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia are correlated with Sokal risk scores and duration of therapy but not trough imatinib plasma levels by Forrest, Donna L, Trainor, Shannon, Brinkman, Ryan R, Barnett, Michael J, Hogge, Donna E, Nevill, Thomas J, Shepherd, John D, Nantel, Stephen H, Toze, Cynthia L, Sutherland, Heather J, Song, Kevin W, Lavoie, Julye C, Power, Maryse M, Abou-Mourad, Yasser, Smith, Clayton A

“…Abstract Cytogenetic and molecular responses to standard-dose imatinib (IM) were correlated with trough IM plasma levels for 78 patients with chronic myeloid…”
Get full text

Long-term follow-up of patients with chronic myeloid leukemia in chronic phase developing sudden blast phase on imatinib therapy by Tantiworawit, Adisak, Power, Maryse M., Barnett, Michael J., Hogge, Donna E., Nantel, Stephen H., Nevill, Thomas J., Shepherd, John D., Song, Kevin W., Sutherland, Heather J., Toze, Cynthia L., Abou-Mourad, Yasser R., Narayanan, Sujaatha, Broady, Raewyn C., Forrest, Donna L.

“…Abstract Sudden blast phase (SBP) is a rare event that occurs in an unpredictable fashion amongst patients with chronic myeloid leukemia (CML) who otherwise…”
Get full text

Novel agents improve survival of transplant patients with multiple myeloma including those with high-risk disease defined by early relapse (<12 months) by Venner, Christopher P., Connors, Joseph M., Sutherland, Heather J., Shepherd, John D., Hamata, Linda, Mourad, Yasser Abou, Barnett, Michael J., Broady, Raewyn, Forrest, Donna L., Hogge, Donna E., Nantel, Stephen H., Narayanan, Sujaatha, Nevill, Thomas J., Nitta, Janet, Power, Maryse M., Toze, Cynthia L., Smith, Clayton A., Song, Kevin W.

“…The treatment of multiple myeloma (MM) has changed with the advent of thalidomide, bortezomib, and lenalidomide, the so-called novel agents (NAs). Given the…”
Get full text

Disseminated mucormycosis presenting as transplant-associated thrombotic microangiopathy by Peterson, Erica A, Gerrie, Alina S, Power, Maryse M, Poulin, Micheal P, Dalal, Bakul I, Forrest, Donna L

Get full text

Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Presenting with Advanced Disease or Failing Treatment with Tyrosine Kinase Inhibitors by Nair, Anish P, Barnett, Michael J, Broady, Raewyn C, Hogge, Donna E, Song, Kevin W, Toze, Cynthia L, Nantel, Stephen H, Power, Maryse M, Sutherland, Heather J, Nevill, Thomas J, Abou Mourad, Yasser, Narayanan, Sujaatha, Gerrie, Alina S, Forrest, Donna L

“…Abstract Allogeneic hematopoietic stem cell transplantation (HSCT) remains the only known curative therapy for chronic myeloid leukemia (CML); however, it is…”
Get full text

Correlation between trough imatinib plasma concentration and clinical response in chronic myeloid leukemia by Forrest, Donna L, Trainor, Shannon, Brinkman, Ryan R, Barnett, Michael J, Hogge, Donna E, Nevill, Thomas J, Shepherd, John D, Nantel, Stephen H, Toze, Cynthia L, Sutherland, Heather J, Song, Kevin W, Lavoie, Julye C, Power, Maryse M, Abou-Mourad, Yasser, Smith, Clayton A

Get full text

Improvement in Survival of Patients with FLT3 Mutated Acute Myeloid Leukemia: Results from a Retrospective Canadian Cohort by Ghosh, Shouriyo, Kuchenbauer, Florian, Stubbins, Ryan J, Chung, Shanee, Narayanan, Sujaatha, Nevill, Thomas J., Song, Kevin, Rodrigo, Judith Anula, White, Jennifer, Roy, Claudie, Abou Mourad, Yasser, Nantel, Stephen H., Forrest, Donna L., Toze, Cynthia L., Hay, Kevin A, Power, Maryse, Sanford, David

“…Introduction: FLT3 internal tandem duplication (ITD) mutations have been historically associated with inferior outcomes in patients with acute myeloid leukemia…”
Get full text

Real-World Outcomes of Pfts in Screening for Lung Involvement in Chronic Gvhd Post-Allogeneic Stem Cell Transplant: A Retrospective Study of 387 Patients in British Columbia, Canada by Wan, Bo, Mourad, Yasser Abou, Chung, Shanee, Forrest, Donna L., Kuchenbauer, Florian, Nantel, Stephen H., Narayanan, Sujaatha, Nevill, Thomas J., Power, Maryse, Rodrigo, Judith Anula, Sanford, David, Song, Kevin, Stubbins, Ryan J, Sutherland, Heather J., Toze, Cynthia L., White, Jennifer, Roy, Claudie, Hay, Kevin A

“…Introduction: Lung involvement in chronic graft versus host disease (cGVHD) is an uncommon but potentially devastating complication with significant morbidity…”
Get full text

Spatially Resolved Tumor Microenvironment Predicts Treatment Outcomes in Relapsed/Refractory Hodgkin Lymphoma by Aoki, Tomohiro, Jiang, Aixiang, Xu, Alexander, Yin, Yifan, Gamboa, Alicia, Milne, Katy, Takata, Katsuyoshi, Miyata-Takata, Tomoko, Chung, Shanee, Rai, Shinya, Wu, Shaocheng, Warren, Mary, Strong, Celia, Goodyear, Talia, Morris, Kayleigh, Chong, Lauren C, Hav, Monirath, Colombo, Anthony R, Telenius, Adele, Boyle, Merrill, Ben-Neriah, Susana, Power, Maryse, Gerrie, Alina S, Weng, Andrew P, Karsan, Aly, Roth, Andrew, Farinha, Pedro, Scott, David W, Savage, Kerry J, Nelson, Brad H, Merchant, Akil, Steidl, Christian

“…About a third of patients with relapsed or refractory classic Hodgkin lymphoma (r/r CHL) succumb to their disease after high-dose chemotherapy followed by…”
Get full text

Autologous Stem Cell Transplant Outcome in Classic Hodgkin Lymphoma Patients in the Era of Post-Transplant Brentuximab Vedotin Consolidation by Chung, Shanee, White, Jennifer, Toze, Cynthia L., Sutherland, Heather J., Sanford, David, Rodrigo, Judith Anula, Nevill, Thomas J., Narayanan, Sujaatha, Nantel, Stephen H., Kuchenbauer, Florian, Hay, Kevin A., Forrest, Donna L., Abou Mourad, Yasser, Song, Kevin, Power, Maryse

“…Introduction: Patients newly diagnosed with classic Hodgkin lymphoma (CHL) have over 80% chance of remission with first-line chemotherapy, such as ABVD…”
Get full text

Outcome of Relapsed and Refractory Peripheral T-Cell Lymphoma (PTCL) with Intention for Curative Therapy Incorporating High Dose Chemotherapy and Hematopoietic Stem Cell Transplant (HDC/SCT) by Ngu, Henry S., Parkin, Stephen, Scott, David W., Villa, Diego, Gerrie, Alina S., Toze, Cynthia L., Power, Maryse, Slack, Graham W, Connors, Joseph M., Song, Kevin, Sehn, Laurie H., Savage, Kerry J.

“…▪ Introduction Salvage therapy with high dose chemotherapy and hematopoietic stem cell transplant (HDC/SCT) is recommended for eligible patients (pts) with…”
Get full text

Autologous Stem Cell Transplantation for Treatment with Curative Intent in Adult Patients with Acute Lymphoblastic Lymphoma by Bazin, Jessica L., Abou Mourad, Yasser, Forrest, Donna L., Hay, Kevin, Kuchenbauer, Florian, Nantel, Stephen H., Narayanan, Sujaatha, Nevill, Thomas J., Power, Maryse, Rodrigo, Judith A, Roy, Claudie, Sanford, David, Song, Kevin, Stubbins, Ryan J., Sutherland, Heather J., Toze, Cynthia L., White, Jennifer, Chung, Shanee

Get full text

Clinical Outcomes in Fresh Versus Cryopreserved Hematopoietic Stem Cell Products in British Columbia: A Retrospective Study by Wan, Bo, Lindo, Lorenzo, Cameron, Giovanna, Abou Mourad, Yasser, Chung, Shanee, Forrest, Donna L., Kuchenbauer, Florian, Nantel, Stephen H., Narayanan, Sujaatha, Nevill, Thomas J., Power, Maryse, Rodrigo, Judith A, Sanford, David, Song, Kevin, Stubbins, Ryan J, Sutherland, Heather J., Toze, Cynthia L., White, Jennifer K., Roy, Claudie, Hay, Kevin A.

Get full text